SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-22-001504
Filing Date
2022-03-01
Accepted
2022-03-01 16:00:26
Documents
13
Period of Report
2022-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_030122.htm   iXBRL 8-K 22929
2 EXHIBIT 99.1 exh_991.htm EX-99.1 6893
  Complete submission text file 0001171843-22-001504.txt   202578

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cytk-20220223.xsd EX-101.SCH 3048
4 XBRL LABEL FILE cytk-20220223_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE cytk-20220223_pre.xml EX-101.PRE 22605
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_030122_htm.xml XML 3506
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 22697804
SIC: 2834 Pharmaceutical Preparations